Moderna 20. Apr. 2026 Is It Too Late To Consider Moderna (MRNA) After A 114% One Year Surge? - simplywall.st
Moderna 19. Apr. 2026 Moderna’s mRNA Melanoma Data And Fast Track Status Shape Oncology Story - Yahoo Finance
Moderna 17. Apr. 2026 Updated: Kailera's shares climb after overtaking Moderna's IPO record with $625M raise - FirstWord Pharma
Moderna 23. Jan. 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials - Fierce Biotech